Product Development Opportunity: ArcticDx has created an infrastructure capable of designing, developing and commercializing a molecular diagnostic test. The company has IP, regulatory, medical, marketing and laboratory experience that is based on FDA guidance.
We are seeking partners with IP related to molecular testing. We have a variety of business models that can be tailored to best suit your requirements. Please contact us.
The management team has individually more than seven years experience managing a molecular diagnostic company (Tm Bioscience Corporation). A list of our accomplishments includes:
- The design and development of a clinical molecular diagnostic (genotyping) platform;
- The design and construction of an FDA approved manufacturing facility for molecular diagnostics;
- The design, development and commercialization of 11 molecular diagnostic tests;
- The first FDA approval of a molecular diagnostic test for the diagnosis of a human disease (cystic fibrosis (39 SNP's);
- Regulatory approvals in Canada, USA and Europe;
- Successful sales, marketing, installation and technical training with every national reference laboratory in the United States including Quest, Labcorp, Mayo, Genzyme, Specialty Labs, ARUP…
- Financing this start up through multiple rounds (publicly traded, Toronto Stock Exchange)
- Delloite and Touche, Top 15 in 2006. Top 50 in 2005.
- TSE first place for Investor Relations Award (2004) from more than 3000 companies.
We are proud of our ability to bring genetic discoveries through a regulated process to commercialization. A list of our regulatory achievements is appended in the management section of this website.
